BioSpace News Archive

PolarityTE, Inc., today reported results for calendar fourth quarter and year ended December 31, 2019.

ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of Harrow Health, Inc. (NASDAQ: HROW), announced that it has agreed to a product supply agreement with EyeCare Services Partners (ESP).

Idera Pharmaceuticals, Inc.reported on March 11, 2020 its financial and operational results for the fourth quarter and year ended December 31, 2019.

Data from study on Tumor Treating Fields in combination with anti-PD-1 therapy published in Cancer Immunology, Immunotherapy

Agenus provided a corporate update and reported financial results for the fourth quarter and full year of 2019.

Tetraphase Pharmaceuticals, Inc.today reported financial results for the fourth quarter and year ended December 31, 2019.

Agenus Inc.today announced that the U.S. Food and Drug Administration (FDA) has granted Agenus Fast Track designation for investigation of balstilimab [PD-1] in combination with zalifrelimab [CTLA-4]

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that it has successfully secured securities purchase agreements, or the Purchase Agreements, to raise $43.7 million through a private equity investment (PIPE) in the Company.

Global medical device and solutions supplier expands portfolio in 2020 with therapeutic seating

Willow Biosciences Inc. (“Willow” or “the Company”) (TSX: WLLW; OTCQB: CANSF), is pleased to announce that it has achieved its first major commercial milestone by delivering a proprietary cannabinoid-producing yeast strain to its scale-up development partner, Albany Molecular Research, Inc. (“AMRI”) to begin the process of scaling up production to commercial volumes.